Cusan, M., Cai, S. F., Mohammad, H. P., Krivtsov, A., Chramiec, A., Loizou, E., . . . Armstrong, S. A. (2018). LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML. Blood.
Styl ChicagoCusan, Monica, et al. "LSD1 Inhibition Exerts Its Antileukemic Effect By Recommissioning PU.1- and C/EBPα-dependent Enhancers in AML." Blood 2018.
Citace podle MLACusan, Monica, et al. "LSD1 Inhibition Exerts Its Antileukemic Effect By Recommissioning PU.1- and C/EBPα-dependent Enhancers in AML." Blood 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..